Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Class IC drugs: propafenone and flecainide.

P Puech1, J P Gagnol

  • 1Hospital Saint-Eloi, Montpellier, France.

Cardiovascular Drugs and Therapy
|June 1, 1990
PubMed
Summary

Flecainide and propafenone effectively treat cardiac arrhythmias. However, flecainide carries a higher risk of proarrhythmic effects, particularly at higher doses, compared to propafenone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive Factors of Missed Clinically Significant Prostate Cancers in Men with Negative Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.

The Journal of urology·2020
Same author

How reproducible are classical and new CT-pelvimetry measurements?

Diagnostic and interventional imaging·2019
Same author

Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer.

World journal of urology·2018
Same author

[Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
Same author

[Pathology findings after radical prostatectomy for prostate cancer in patients eligible for active surveillance: Contribution of multiparametric MRI to treatment decision].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
Same author

Intralayer and interlayer electron-phonon interactions in twisted graphene heterostructures.

Nature communications·2018

Area of Science:

  • Cardiology
  • Clinical Pharmacology

Background:

  • Flecainide and propafenone are antiarrhythmic drugs.
  • Cardiac arrhythmias require effective treatment options.

Purpose of the Study:

  • To review recent clinical data on the efficacy and side-effect profiles of flecainide and propafenone.
  • To compare the clinical effectiveness and safety of these two antiarrhythmic agents.

Main Methods:

  • Review of recently published clinical data.
  • Analysis of efficacy for various cardiac arrhythmias.
  • Evaluation of noncardiac and proarrhythmic side effects.

Main Results:

  • Both flecainide and propafenone demonstrate clinical efficacy in managing ventricular and supraventricular arrhythmias.
  • Included are termination of atrial fibrillation, control of junctional tachycardias, and ventricular arrhythmias.
  • Noncardiac side effects were similar between the two drugs.
  • Flecainide showed a higher incidence of proarrhythmic effects than propafenone, especially at doses exceeding 400 mg.

Conclusions:

  • Flecainide and propafenone are effective antiarrhythmic treatments.
  • Clinicians should consider the increased proarrhythmic risk associated with flecainide, particularly at higher dosages.

Related Experiment Videos